Concurrent chemoradiation therapy in cervical cancer: Prognostic factors, toxicity, and long-term survival in a center of reference for gynecologic cancer. This is an ASCO Meeting Abstract from the ...
August 9, 2007 — The improved dose distribution achieved with the new radiotherapy technique reduces clinical toxicities compared with conventional wedge-based radiotherapy, researchers say. Reporting ...
Early initiation of salvage radiotherapy is associated with improved metastasis-free survival in patients with relapsed prostate cancer following prostatectomy. Survival outcomes in men with ...
Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional ...
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative ...
In this phase 3 trial, researchers aimed to assess morbidity and efficacy of 3-week hypofractionated locoregional radiotherapy compared to 5-week radiotherapy.
In patients with head and neck cancer, a strategy to reduce the radiation dose to dysphagia-and aspiration-related structures improved swallowing and other functional outcomes compared with standard ...
AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent and newly diagnosed glioblastoma (GBM) patients when given in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results